Wolverine Trading
GH icon

Wolverine Trading’s Guardant Health GH Stock Holding History

Wolverine Trading’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,700
Closed -$815K – 5143
2024
Q4 		$815K Sell
26,700
-8,300
-24% -$233K ﹤0.01% 2869
2024
Q3 		$801K Buy
35,000
+5,600
+19% +$158K ﹤0.01% 2586
2024
Q2 		$849K Sell
29,400
-4,100
-12% -$95.5K ﹤0.01% 2348
2024
Q1 		$691K Buy
+33,500
New +$718K ﹤0.01% 2544
2023
Q1 		– Sell
-9,800
Closed -$267K – 4496
2022
Q4 		$267K Sell
9,800
-11,100
-53% -$508K ﹤0.01% 2872
2022
Q3 		$1.12M Buy
+20,900
New +$1.07M ﹤0.01% 1850
2022
Q2 		– Sell
-14,100
Closed -$945K – 4950
2022
Q1 		$945K Sell
14,100
-4,700
-25% -$322K ﹤0.01% 2498
2021
Q4 		$1.88M Buy
18,800
+7,600
+68% +$786K ﹤0.01% 1954
2021
Q3 		$1.36M Sell
11,200
-200
-2% -$23.8K ﹤0.01% 2598
2021
Q2 		$1.46M Buy
11,400
+4,700
+70% +$632K ﹤0.01% 2339
2021
Q1 		$983K Buy
6,700
+3,700
+123% +$559K ﹤0.01% 2783
2020
Q4 		$378K Buy
+3,000
New +$345K ﹤0.01% 3484

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's GH Position: Q4 2024 in Review

Wolverine Trading sold out of Guardant Health (GH) in Q4 2024, closing a stake of 17,022 shares — an estimated $479K sold.

Wolverine Trading first reported a position in GH in Q4 2021 and held it in 7 quarters. The position peaked at $2.08M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Wolverine Trading reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 17,022 Guardant Health shares in Q4 2024, an estimated $479K.
  • Wolverine Trading first reported a position in Guardant Health in Q4 2021 and held it in 7 quarters.
  • Wolverine Trading's Guardant Health position peaked at $2.08M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.